AstraZeneca, the UK's largest listed company by market value, reported revenue growth of 11% to $14.46 billion for the ...

LONDON] British pharmaceutical giant AstraZeneca on Tuesday (Jul 29) said net profit rose 27 per cent in the second quarter, ...

AstraZeneca PLC (NASDAQ: AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the United States by 2030, it ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the United States. Revenue climbed 12 percent to ...

Astrazeneca has revealed a jump in revenue from cancer drugs amid rumours its boos is eyeing a listing across the pond. Total ...

The proposed manufacturing facility in Virginia would be the linchpin of a $50 billion plan that AstraZeneca announced. It ...

The company hopes to move on from scandals in China, after indicating that any impact from probes in its second-biggest ...

Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology ...

AstraZeneca has announced an ambitious $50 billion investment in the United States, aiming to significantly expand its ...